Yun-Cai Liu

Title: Innovations of Yun-Cai Liu in Glycosylation Inhibition

Introduction

Yun-Cai Liu is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation inhibition. His work has implications for the development of biologically active polypeptides, which are crucial in various medical applications.

Latest Patents

Yun-Cai Liu holds a patent for a method related to the recombinant production of antigen non-specific glycosylation. This patent includes polypeptides, polynucleotides, and fragments that serve as inhibitors for both antigen-specific and antigen-non-specific glycosylation. The method he developed allows for the recombinant production of biologically active polypeptides from a structural gene encoding the polypeptide.

Career Highlights

Throughout his career, Liu has worked with prominent organizations, including Kirin Beer Kabushiki Kaisha and the La Jolla Institute for Allergy and Immunology. His experience in these institutions has enriched his expertise and contributed to his innovative work in biotechnology.

Collaborations

Yun-Cai Liu has collaborated with esteemed colleagues such as Kimishige Ishizaka and Toshifumi Mikayama. These collaborations have fostered advancements in research and development within the field.

Conclusion

Yun-Cai Liu's contributions to glycosylation inhibition and his innovative methods in biotechnology highlight his importance as an inventor. His work continues to influence the development of biologically active polypeptides, showcasing the impact of his research on the scientific community.